tiprankstipranks
Quidelortho Corporation (CH:QL1A)
NASDAQ:QL1A
Switzerland Market
QL1A
QuidelOrtho
RESEARCH TOOLSreports

QuidelOrtho (QL1A) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

QL1A Analyst Ratings

Hold
6Ratings
Hold
1 Buy
4 Hold
1 Sell
Based on 6 analysts giving stock ratings to
QuidelOrtho
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QL1A Stock 12 Month Forecast

Average Price Target

$10.01
Based on 6 Wall Street analysts offering 12 month price targets for QuidelOrtho in the last 3 months. The average price target is $10.01 with a high forecast of $10.52 and a low forecast of $9.71. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$10.52Average Price Target$10.01Lowest Price Target$9.71
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:QL1A
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF8.9→CHF9.71
Sell
―
Assigned
07/01/26
QuidelOrtho price target raised to $12 from $11 at JPMorganQuidelOrtho price target raised to $12 from $11 at JPMorgan
Jefferies Analyst forecast on CH:QL1A
Tycho Peterson
Jefferies
Jefferies
CHF10.12
Hold
―
Downgraded
05/07/26
QuidelOrtho downgraded to Hold from Buy at JefferiesQuidelOrtho downgraded to Hold from Buy at Jefferies
UBS Analyst forecast on CH:QL1A
Lu Li
UBS
UBS
CHF13.76→CHF9.71
Hold
―
Assigned
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medline (NASDAQ: MDLN), QuidelOrtho (NASDAQ: QDEL) and Siemens Healthineers AG (Other OTC: SEMHF)
William Blair Analyst forecast on CH:QL1A
Andrew Brackmann
William Blair
William Blair
CHF9.44→
Hold
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Climb Bio (NASDAQ: CLYM) and Henry Schein (NASDAQ: HSIC)
Citi Analyst forecast on CH:QL1A
Patrick B Donnelly
Citi
Citi
CHF24.28→CHF10.52
Hold
―
Assigned
05/06/26
QuidelOrtho price target lowered to $13 from $30 at CitiQuidelOrtho price target lowered to $13 from $30 at Citi
Craig-Hallum Analyst forecast on CH:QL1A
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Schrodinger (NASDAQ: SDGR)
RBC Capital Analyst forecast on CH:QL1A
Conor McNamara
RBC Capital
RBC Capital
CHF48.56→CHF50.17
Buy
―
Reiterated
09/02/25
RBC Capital Keeps Their Buy Rating on QuidelOrtho (QDEL)
Raymond James Analyst forecast on CH:QL1A
Andrew Cooper
Raymond James
Raymond James
CHF48.56→CHF44.51
Buy
―
Reiterated
08/06/25
QuidelOrtho price target lowered to $55 from $60 at Raymond JamesQuidelOrtho price target lowered to $55 from $60 at Raymond James
Nephron Analyst forecast on CH:QL1A
Jack Meehan
Nephron
Nephron
CHF32.37
Hold
―
Downgraded
07/09/25
QuidelOrtho downgraded to Hold from Buy at Nephron ResearchQuidelOrtho downgraded to Hold from Buy at Nephron Research
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:QL1A
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF8.9→CHF9.71
Sell
―
Assigned
07/01/26
QuidelOrtho price target raised to $12 from $11 at JPMorganQuidelOrtho price target raised to $12 from $11 at JPMorgan
Jefferies Analyst forecast on CH:QL1A
Tycho Peterson
Jefferies
Jefferies
CHF10.12
Hold
―
Downgraded
05/07/26
QuidelOrtho downgraded to Hold from Buy at JefferiesQuidelOrtho downgraded to Hold from Buy at Jefferies
UBS Analyst forecast on CH:QL1A
Lu Li
UBS
UBS
CHF13.76→CHF9.71
Hold
―
Assigned
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medline (NASDAQ: MDLN), QuidelOrtho (NASDAQ: QDEL) and Siemens Healthineers AG (Other OTC: SEMHF)
William Blair Analyst forecast on CH:QL1A
Andrew Brackmann
William Blair
William Blair
CHF9.44→
Hold
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Climb Bio (NASDAQ: CLYM) and Henry Schein (NASDAQ: HSIC)
Citi Analyst forecast on CH:QL1A
Patrick B Donnelly
Citi
Citi
CHF24.28→CHF10.52
Hold
―
Assigned
05/06/26
QuidelOrtho price target lowered to $13 from $30 at CitiQuidelOrtho price target lowered to $13 from $30 at Citi
Craig-Hallum Analyst forecast on CH:QL1A
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Schrodinger (NASDAQ: SDGR)
RBC Capital Analyst forecast on CH:QL1A
Conor McNamara
RBC Capital
RBC Capital
CHF48.56→CHF50.17
Buy
―
Reiterated
09/02/25
RBC Capital Keeps Their Buy Rating on QuidelOrtho (QDEL)
Raymond James Analyst forecast on CH:QL1A
Andrew Cooper
Raymond James
Raymond James
CHF48.56→CHF44.51
Buy
―
Reiterated
08/06/25
QuidelOrtho price target lowered to $55 from $60 at Raymond JamesQuidelOrtho price target lowered to $55 from $60 at Raymond James
Nephron Analyst forecast on CH:QL1A
Jack Meehan
Nephron
Nephron
CHF32.37
Hold
―
Downgraded
07/09/25
QuidelOrtho downgraded to Hold from Buy at Nephron ResearchQuidelOrtho downgraded to Hold from Buy at Nephron Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering QuidelOrtho

3 Months
Conor McNamaraRBC Capital
Success Rate
6/28 ratings generated profit
21%
Average Return
-8.11%
Copying Conor McNamara's trades and holding each position for 3 Months would result in 21.43% of your transactions generating a profit, with an average return of -8.11% per trade.
1 Year
Conor McNamaraRBC Capital
Success Rate
0/28 ratings generated profit
0%
Average Return
-35.95%
Copying Conor McNamara's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.95% per trade.
2 Years
Conor McNamaraRBC Capital
Success Rate
0/28 ratings generated profit
0%
Average Return
-55.54%
Copying Conor McNamara's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -55.54% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QL1A Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
1
0
0
0
Buy
1
1
2
2
1
Hold
7
6
6
6
4
Sell
1
2
2
2
2
Strong Sell
0
0
0
0
0
total
10
10
10
10
7
In the current month, QL1A has received 1 Buy Ratings, 4 Hold Ratings, and 2 Sell Ratings. QL1A average Analyst price target in the past 3 months is 10.01.
Each month's total comprises the sum of three months' worth of ratings.

QL1A Financial Forecast

QL1A Earnings Forecast

Next quarter’s earnings estimate for QL1A is -$0.02 with a range of -$0.05 to <$0.01. The previous quarter’s EPS was -$0.03. QL1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QL1A has Performed in-line its overall industry.
Next quarter’s earnings estimate for QL1A is -$0.02 with a range of -$0.05 to <$0.01. The previous quarter’s EPS was -$0.03. QL1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QL1A has Performed in-line its overall industry.

QL1A Sales Forecast

Next quarter’s sales forecast for QL1A is $502.03M with a range of $497.13M to $507.46M. The previous quarter’s sales results were $501.23M. QL1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QL1A has Performed in-line its overall industry.
Next quarter’s sales forecast for QL1A is $502.03M with a range of $497.13M to $507.46M. The previous quarter’s sales results were $501.23M. QL1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QL1A has Performed in-line its overall industry.

QL1A Stock Forecast FAQ

What is CH:QL1A’s average 12-month price target, according to analysts?
Based on analyst ratings, Quidelortho Corporation’s 12-month average price target is 10.01.
    What is CH:QL1A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:QL1A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Quidelortho Corporation a Buy, Sell or Hold?
        Quidelortho Corporation has a consensus rating of Hold, which is based on 1 buy ratings, 4 hold ratings and 1 sell ratings.
          What is Quidelortho Corporation’s share price target?
          The average share price target for Quidelortho Corporation is 10.01. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $10.52 ,and the lowest forecast is $9.71. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Quidelortho Corporation?
            Quidelortho Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Quidelortho Corporation?
              To buy shares of CH:QL1A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.